Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial - Pruthi, RK; Mathew, P; Valentino, LA (Thromb Haemost, 2007)